Zerodol Tablet contains Aceclofenac 100 mg, a non-steroidal anti-inflammatory drug (NSAID) widely used for its analgesic, anti-inflammatory, and antipyretic properties. It is primarily indicated for the management of pain and inflammation associated with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Aceclofenac exerts its therapeutic effects by selectively inhibiting cyclooxygenase (COX), leading to a reduction in the synthesis of prostaglandins, which are mediators of inflammation and pain. Zerodol is effective in alleviating symptoms such as joint pain, swelling, and stiffness, thereby improving patient mobility and quality of life. The tablet is generally well-tolerated when administered at recommended doses; however, caution is advised in patients with a history of gastrointestinal ulcers, bleeding disorders, or renal and hepatic impairment. Common adverse effects may include gastrointestinal discomfort, nausea, and dizziness. It is contraindicated in individuals with known hypersensitivity to Aceclofenac or other NSAIDs. Zerodol should be used under medical supervision, especially in patients with cardiovascular risk factors, and is not recommended during pregnancy or lactation unless deemed necessary by a healthcare professional. Proper adherence to prescribed dosage and duration is essential to minimize potential side effects and ensure optimal therapeutic outcomes.